LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
-0.76%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$5.82B
AUM Growth
+$5.82B
(-16%)
Cap. Flow
-$995M
Cap. Flow
% of AUM
-17.1%
Top 10 Holdings %
Top 10 Hldgs %
53.6%
Holding
563
New
115
Increased
52
Reduced
86
Closed
174
Top Buys
| 1 |
VMW
VMware, Inc
VMW
|
$286M |
| 2 |
eBay
EBAY
|
$211M |
| 3 |
T-Mobile US
TMUS
|
$171M |
| 4 |
Stanley Black & Decker
SWK
|
$134M |
| 5 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
$101M |
Top Sells
| 1 |
Merck
MRK
|
$185M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$166M |
| 3 |
HP
HPQ
|
$136M |
| 4 |
Cigna
CI
|
$126M |
| 5 |
Dell
DELL
|
$97.8M |
Sector Composition
| 1 | Healthcare | 21.43% |
| 2 | Technology | 13.81% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Energy | 10.29% |
| 5 | Financials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pyxis Oncology
PYXS
$91.2M
| $12.8M | 0.13% |
+1,162,332
| New | +$12.8M |
|
52
Wells Fargo
WFC
$258B
| $12.2M | 0.12% |
+255,060
| New | +$12.2M |
|
53
Cisco
CSCO
$268B
| $11.9M | 0.12% |
187,407
+67,584
| +56% | +$4.28M |
|
|
DOYU
54
DouYu International Holdings
DOYU
$244M
| $11.5M | 0.12% |
4,355,435
-78,383
| -2% | -$207K |
|
|
SWTX
55
DELISTED
SpringWorks Therapeutics
SWTX
| $11.5M | 0.12% |
185,261
| – | – |
|
56
Praxis Precision Medicines
PRAX
$980M
| $10.9M | 0.11% |
552,579
+58,000
| +12% | +$1.14M |
|
57
Comcast
CMCSA
$125B
| $10.8M | 0.11% |
213,606
-26,194
| -11% | -$1.32M |
|
58
TechnipFMC
FTI
$15.7B
| $10.7M | 0.11% |
1,805,647
-1,270,231
| -41% | -$7.52M |
|
59
PayPal
PYPL
$66.5B
| $10.4M | 0.1% |
54,985
-16,953
| -24% | -$3.2M |
|
60
CME Group
CME
$97.1B
| $10.3M | 0.1% |
45,004
| – | – |
|
61
Zoom
ZM
$25B
| $10.1M | 0.1% |
54,736
-141,077
| -72% | -$25.9M |
|
62
Vor Biopharma
VOR
$253M
| $9.96M | 0.1% |
857,308
+200,000
| +30% | +$2.32M |
|
63
iShares China Large-Cap ETF
FXI
$6.65B
| $9.34M | 0.09% |
255,416
-1,398,424
| -85% | -$51.2M |
|
|
KDNY
64
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $9.04M | 0.09% |
+554,250
| New | +$9.04M |
|
65
Adicet Bio
ACET
$60.8M
| $9.01M | 0.09% |
515,000
+240,000
| +87% | +$4.2M |
|
66
PENN Entertainment
PENN
$2.86B
| $8.56M | 0.09% |
165,175
-53,746
| -25% | -$2.79M |
|
67
Rigel Pharmaceuticals
RIGL
$710M
| $7.91M | 0.08% |
2,984,400
+1,859,400
| +165% | +$4.93M |
|
68
GH Research
GHRS
$870M
| $7.81M | 0.08% |
334,592
-10,408
| -3% | -$243K |
|
|
RACB
69
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $7.78M | 0.08% |
800,000
| – | – |
|
70
Spyre Therapeutics
SYRE
$1.02B
| $6.89M | 0.07% |
1,450,638
+844,000
| +139% | +$4.01M |
|
71
Capital One
COF
$142B
| $6.89M | 0.07% |
47,474
-145,939
| -75% | -$21.2M |
|
|
AMRS
72
DELISTED
Amyris Inc.
AMRS
| $6.7M | 0.07% |
+1,239,200
| New | +$6.7M |
|
|
ATVI
73
DELISTED
Activision Blizzard Inc.
ATVI
| $6.24M | 0.06% |
+93,800
| New | +$6.24M |
|
74
Norwegian Cruise Line
NCLH
$11.5B
| $6.22M | 0.06% |
+300,000
| New | +$6.22M |
|
75
KalVista Pharmaceuticals
KALV
$713M
| $6.22M | 0.06% |
470,000
+350,000
| +292% | +$4.63M |
|